
Paul Garofolo discusses the engineering of phages to combat bacterial infections more effectively.
Phages are viruses that attack bacteria. People have been using phages to treat infections for over a hundred years, but in most cases they just don't work as well as antibiotics. Paul Garofolo is the co-founder and CEO of Locus Biosciences. His problem is this: How do you genetically engineer phages to be more effective at curing disease? In this episode, Paul explains: Why wild phages never completely wipe out a bacterial infection How to engineer phages with CRISPR to kill bacteria more effectively The clinical trial testing phage therapy for chronic, recurrent UTIs Why persistent bacteria may contribute to autoimmune conditions like Crohn's disease How to use robots and AI to create phage cocktails from wastewater Connect with us: Follow Jacob Goldstein on LinkedIn , X and Instagram Email us at problem@pushkin.fm Follow Pushkin on Instagram , LinkedIn or X Listen to Jacob’s other show, Business History To listen to the show early and ad free, sign up for Pushkin+ See omnystudio.com/listener for privacy information.
Guest: Paul Garofolo
Organizations: Locus Biosciences, Pushkin, iHeartPodcasts, CRISPR
Places: Crohn's disease, UTIs
Explore listener stats, chart rankings, contacts and more on the What's Your Problem? podcast page.